跳到正文
← 返回论文列表与筛选
阅读说明

本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。

DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。

本页为预印本版本;arXiv 收录、作者填写的期刊信息以及作者既有发表经历,都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对,只展示已核实例,档案仍可能误合并。

引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。

关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。

分类依据与纠错

AI 根据所提供的论文材料归类:摘要直接讨论潜在结果、混杂选择偏差及跨亚组处理效应估计。

反馈分类问题

正在核对关联版本…

代码、数据与补充材料

正在核对对应版本的资源…

关注这篇论文的作者
Zhixuan Chu
Stephen L. Rathbun
Sheng Li

篮式试验中处理效应估计的多任务对抗学习

研究问题
在共享基因突变但肿瘤类型不同的人群中,如何面对反事实缺失及混杂导致的处理选择偏差,估计跨亚组的潜在结果和处理效应?
方法与思路
作者提出 MTAL,结合特征选择、多任务表征学习与对抗学习估计不同肿瘤类型的潜在结果,并用合成篮式试验及两个基准评估。
材料陈述的贡献
摘要提出以篮式试验说明的跨亚组因果推断设置,并称 MTAL 在合成数据、IHDP 和 News 基准上优于所比较的方法,未给出具体数值。
阅读关注点
应核对目标效应、跨亚组共享信息的依据、因果识别条件和对抗学习目标,以及基准中的反事实来源、比较设置和误差评价。
阅读边界
所给版本为 arXiv 预印本,同行评审或接收未核实;摘要未列识别条件或真实临床验证,基准优势不能直接推及实际药物疗效。

原文摘要

Estimating treatment effects from observational data provides insights about causality guiding many real-world applications such as different clinical study designs, which are the formulations of trials, experiments, and observational studies in medical, clinical, and other types of research. In this paper, we describe causal inference for application in a novel clinical design called basket trial that tests how well a new drug works in patients who have different types of cancer that all have the same mutation. We propose a multi-task adversarial learning (MTAL) method, which incorporates feature selection multi-task representation learning and adversarial learning to estimate potential outcomes across different tumor types for patients sharing the same genetic mutation but having different tumor types. In our paper, the basket trial is employed as an intuitive example to present this new causal inference setting. This new causal inference setting includes, but is not limited to basket trials. This setting has the same challenges as the traditional causal inference problem, i.e., missing counterfactual outcomes under different subgroups and treatment selection bias due to confounders. We present the practical advantages of our MTAL method for the analysis of synthetic basket trial data and evaluate the proposed estimator on two benchmarks, IHDP and News. The results demonstrate the superiority of our MTAL method over the competing state-of-the-art methods.

笔记与分组